# PodcastOne, Inc.: financial statements, quarterly

PODC · Nasdaq · CIK 1940177 · [Technology](/sectors/technology.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/podc.md) · [Financials](/companies/podc/financials.md) · [Filings](/companies/podc/filings.md) · [Insiders](/companies/podc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/podc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [10.5](/filings/0001437749-24-035387.md) | [10.4](/filings/0001437749-25-003963.md) | [11.7 d](/filings/0001437749-25-022022.md) | [13.2](/filings/0001437749-25-026905.md) | [12.2](/filings/0001437749-25-035111.md) | [12.7](/filings/0001437749-26-004107.md) | [14.1 d](/filings/0001437749-26-021988.md) | [15.0](/filings/0001437749-26-028050.md) | [15.2](/filings/0001437749-25-035111.md) | [15.9](/filings/0001437749-26-004107.md) | [15.7 d](/filings/0001437749-26-021988.md) | [16.1](/filings/0001437749-26-028050.md) |
| Cost of revenue | $m | [9.1](/filings/0001437749-24-035387.md) | [9.4](/filings/0001437749-25-003963.md) | [10.7 d](/filings/0001437749-25-022022.md) | [11.7](/filings/0001437749-25-026905.md) | [11.1](/filings/0001437749-25-035111.md) | [12.0](/filings/0001437749-26-004107.md) | [12.6 d](/filings/0001437749-26-021988.md) | [13.6](/filings/0001437749-26-028050.md) | [13.5](/filings/0001437749-25-035111.md) | [13.2](/filings/0001437749-26-004107.md) | [13.8 d](/filings/0001437749-26-021988.md) | [14.2](/filings/0001437749-26-028050.md) |
| Research and development | $m | [0.0](/filings/0001437749-24-035387.md) | [0.0](/filings/0001437749-25-003963.md) | [0.0 d](/filings/0001437749-25-022022.md) | [0.0](/filings/0001437749-25-026905.md) | [0.0](/filings/0001437749-25-035111.md) | [0.0](/filings/0001437749-26-004107.md) | [0.0 d](/filings/0001437749-26-021988.md) | [0.0](/filings/0001437749-26-028050.md) | [0.0](/filings/0001437749-25-035111.md) | [0.0](/filings/0001437749-26-004107.md) | [0.0 d](/filings/0001437749-26-021988.md) | [0.0](/filings/0001437749-26-028050.md) |
| Operating income | $m | [(1.4)](/filings/0001437749-24-035387.md) | [(2.6)](/filings/0001437749-25-003963.md) | [(1.2) d](/filings/0001437749-25-022022.md) | [(1.4)](/filings/0001437749-25-026905.md) | [(1.7)](/filings/0001437749-25-035111.md) | [(1.6)](/filings/0001437749-26-004107.md) | [(1.8) d](/filings/0001437749-26-021988.md) | [(1.1)](/filings/0001437749-26-028050.md) | [(1.0)](/filings/0001437749-25-035111.md) | [(0.2)](/filings/0001437749-26-004107.md) | [(0.5) d](/filings/0001437749-26-021988.md) | [(1.6)](/filings/0001437749-26-028050.md) |
| Interest expense | $m | [0.7](/filings/0001437749-23-032627.md) | [0.0](/filings/0001437749-24-003801.md) | [0.0 d](/filings/0001437749-24-021729.md) | [0.0](/filings/0001437749-24-026430.md) | [0.0](/filings/0001437749-24-035387.md) | [0.0](/filings/0001437749-25-003963.md) | [0.0 d](/filings/0001437749-25-022022.md) | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.0](/filings/0001437749-24-035387.md) | [0.0](/filings/0001437749-25-003963.md) | [0.1 d](/filings/0001437749-25-022022.md) | [0.0](/filings/0001437749-25-026905.md) | [0.0](/filings/0001437749-25-035111.md) | [0.0](/filings/0001437749-26-004107.md) | [0.0 d](/filings/0001437749-26-021988.md) | [0.0](/filings/0001437749-26-028050.md) | [0.0](/filings/0001437749-25-035111.md) | [0.0](/filings/0001437749-26-004107.md) | [0.0 d](/filings/0001437749-26-021988.md) | [0.0](/filings/0001437749-26-028050.md) |
| Net income | $m | [(10.9)](/filings/0001437749-25-003963.md) | [(2.6)](/filings/0001437749-25-003963.md) | [(1.0) d](/filings/0001437749-25-022022.md) | [(1.4)](/filings/0001437749-26-004107.md) | [(1.7)](/filings/0001437749-26-004107.md) | [(1.6)](/filings/0001437749-26-004107.md) | [(1.8) d](/filings/0001437749-26-021988.md) | [(1.1)](/filings/0001437749-26-028050.md) | [(1.0)](/filings/0001437749-26-004107.md) | [(0.2)](/filings/0001437749-26-004107.md) | [(0.5) d](/filings/0001437749-26-021988.md) | [(1.6)](/filings/0001437749-26-028050.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | [(0.52)](/filings/0001437749-24-035387.md) | [(0.11)](/filings/0001437749-25-003963.md) | not reported | [(0.06)](/filings/0001437749-25-026905.md) | [(0.07)](/filings/0001437749-25-035111.md) | [(0.06)](/filings/0001437749-26-004107.md) | not reported | [(0.04)](/filings/0001437749-26-028050.md) | [(0.04)](/filings/0001437749-25-035111.md) | [(0.01)](/filings/0001437749-26-004107.md) | not reported | [(0.05)](/filings/0001437749-26-028050.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.5](/filings/0001437749-24-035387.md) | [1.4](/filings/0001437749-24-003801.md) | [1.4](/filings/0001437749-25-022022.md) | [0.9](/filings/0001437749-24-026430.md) | [1.4](/filings/0001437749-24-035387.md) | [0.6](/filings/0001437749-25-003963.md) | [1.1](/filings/0001437749-26-021988.md) | [1.9](/filings/0001437749-25-026905.md) | [2.7](/filings/0001437749-25-035111.md) | [3.4](/filings/0001437749-26-004107.md) | [3.5](/filings/0001437749-26-028050.md) | [7.0](/filings/0001437749-26-028050.md) |
| Current assets | $m | [11.2](/filings/0001437749-23-032627.md) | [9.6](/filings/0001437749-24-003801.md) | [8.6](/filings/0001437749-25-022022.md) | [9.2](/filings/0001437749-24-026430.md) | [8.3](/filings/0001437749-24-035387.md) | [6.6](/filings/0001437749-25-003963.md) | [7.6](/filings/0001437749-26-021988.md) | [8.8](/filings/0001437749-25-026905.md) | [9.2](/filings/0001437749-25-035111.md) | [11.7](/filings/0001437749-26-004107.md) | [11.1](/filings/0001437749-26-028050.md) | [14.7](/filings/0001437749-26-028050.md) |
| Total assets | $m | [28.4](/filings/0001437749-23-032627.md) | [27.7](/filings/0001437749-24-003801.md) | [24.1](/filings/0001437749-25-022022.md) | [24.0](/filings/0001437749-24-026430.md) | [23.1](/filings/0001437749-24-035387.md) | [20.6](/filings/0001437749-25-003963.md) | [21.2](/filings/0001437749-26-021988.md) | [22.3](/filings/0001437749-25-026905.md) | [22.6](/filings/0001437749-25-035111.md) | [24.7](/filings/0001437749-26-004107.md) | [29.2](/filings/0001437749-26-028050.md) | [38.3](/filings/0001437749-26-028050.md) |
| Current liabilities | $m | [10.9](/filings/0001437749-23-032627.md) | [10.9](/filings/0001437749-24-003801.md) | [7.7](/filings/0001437749-25-022022.md) | [8.3](/filings/0001437749-24-026430.md) | [7.6](/filings/0001437749-24-035387.md) | [5.6](/filings/0001437749-25-003963.md) | [6.1](/filings/0001437749-26-021988.md) | [7.6](/filings/0001437749-25-026905.md) | [7.9](/filings/0001437749-25-035111.md) | [8.8](/filings/0001437749-26-004107.md) | [12.0](/filings/0001437749-26-028050.md) | [14.1](/filings/0001437749-26-028050.md) |
| Total liabilities | $m | [11.1](/filings/0001437749-23-032627.md) | [11.2](/filings/0001437749-24-003801.md) | [7.8](/filings/0001437749-25-022022.md) | [8.3](/filings/0001437749-24-026430.md) | [7.6](/filings/0001437749-24-035387.md) | [5.6](/filings/0001437749-25-003963.md) | [6.1](/filings/0001437749-26-021988.md) | [7.6](/filings/0001437749-25-026905.md) | [7.9](/filings/0001437749-25-035111.md) | [8.9](/filings/0001437749-26-004107.md) | [12.1](/filings/0001437749-26-028050.md) | [14.2](/filings/0001437749-26-028050.md) |
| Shareholders' equity | $m | [17.3](/filings/0001437749-25-003963.md) | [16.5](/filings/0001437749-25-003963.md) | [16.3](/filings/0001437749-26-021988.md) | [15.7](/filings/0001437749-26-004107.md) | [15.5](/filings/0001437749-26-004107.md) | [15.0](/filings/0001437749-26-004107.md) | [15.1](/filings/0001437749-26-028050.md) | [14.7](/filings/0001437749-26-028050.md) | [14.7](/filings/0001437749-26-004107.md) | [15.8](/filings/0001437749-26-004107.md) | [17.1](/filings/0001437749-26-028050.md) | [24.1](/filings/0001437749-26-028050.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [627 d](/filings/0001437749-24-035387.md) | [1,205 d](/filings/0001437749-25-003963.md) | [425 d](/filings/0001437749-25-022022.md) | [(480)](/filings/0001437749-25-026905.md) | [525 d](/filings/0001437749-25-035111.md) | [(763) d](/filings/0001437749-26-004107.md) | [506 d](/filings/0001437749-26-021988.md) | [903](/filings/0001437749-26-028050.md) | [877 d](/filings/0001437749-25-035111.md) | [579 d](/filings/0001437749-26-004107.md) | [93.0 d](/filings/0001437749-26-021988.md) | [(447)](/filings/0001437749-26-028050.md) |
| Capital expenditure | $k | [68.0 d](/filings/0001437749-24-035387.md) | [139 d](/filings/0001437749-25-003963.md) | [63.0 d](/filings/0001437749-25-022022.md) | [74.0](/filings/0001437749-25-026905.md) | [61.0 d](/filings/0001437749-25-035111.md) | [20.0 d](/filings/0001437749-26-004107.md) | [(1.0) d](/filings/0001437749-26-021988.md) | [112](/filings/0001437749-26-028050.md) | [0.0 d](/filings/0001437749-25-035111.md) | [(90.0) d](/filings/0001437749-26-004107.md) | [0.0 d](/filings/0001437749-26-021988.md) | [0.0](/filings/0001437749-26-028050.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2022-06-30) | Q1 FY2024 (2023-06-30) |
| --- | --- | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [148](/filings/0001213900-23-067375.md) | [20.0](/filings/0001213900-23-067375.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 30,252,696 at 2026-08-12, from the cover of the [10-Q filed 2026-08-14](/filings/0001437749-26-028050.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.